Improving Public Health with Innovative Medicines and Caring Expertise
Metabolic Database
SBK harnesses its industry-leading AI-powered metabolic research platform to integrate cutting-edge global R&D breakthroughs. Through multi-dimensional data modeling, it precisely identifies clinical metabolic deficiencies in drug candidates. Centered on an AI-driven drug metabolism analysis and intelligent design system, the platform dynamically collects cross-species metabolic data to build a comprehensive AI-powered metabolic database, enabling end-to-end R&D iteration from early discovery to clinical translation. This approach targets unmet clinical needs and delivers innovative therapies with precision.
R&D Pipeline-Respiratory System
With a focus on the respiratory field, we are dedicated to developing the world’s most advanced, metabolically differentiated therapies. Several products are already in clinical trial stages.
R&D Pipeline-Cardiovascular & Cerebrovascular
With a focus on cardiovascular and cerebrovascular diseases, we are committed to developing the world’s most advanced and differentiated therapies in cardiovascular metabolism. Several products are already in clinical trial stages.
News Center
